Target Price | $47.46 |
Price | $28.38 |
Potential |
67.24%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Acadia Healthcare Company, Inc. 2026 .
The average Acadia Healthcare Company, Inc. target price is $47.46.
This is
67.24%
register free of charge
$72.00
153.70%
register free of charge
$35.00
23.33%
register free of charge
|
|
A rating was issued by 14 analysts: 11 Analysts recommend Acadia Healthcare Company, Inc. to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Acadia Healthcare Company, Inc. stock has an average upside potential 2026 of
67.24%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 3.15 | 3.34 |
7.69% | 5.83% | |
EBITDA Margin | 21.30% | 20.67% |
2.36% | 2.97% | |
Net Margin | 8.09% | 7.13% |
1,175.62% | 11.86% |
12 Analysts have issued a sales forecast Acadia Healthcare Company, Inc. 2025 . The average Acadia Healthcare Company, Inc. sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Acadia Healthcare Company, Inc. EBITDA forecast 2025. The average Acadia Healthcare Company, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Acadia Healthcare Company, Inc. Analysts have issued a net profit forecast 2025. The average Acadia Healthcare Company, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.78 | 2.59 |
1,258.33% | 6.83% | |
P/E | 10.95 | |
EV/Sales | 1.43 |
8 Analysts have issued a Acadia Healthcare Company, Inc. forecast for earnings per share. The average Acadia Healthcare Company, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Acadia Healthcare Company, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Mizuho |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Jan 07 2025 |
Analyst Rating | Date |
---|---|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 03 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Mar 03 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Jan 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.